welcome
Benzinga

Benzinga

Business

Business & Economics

Is ARK Innovation ETF a real comeback or just another short-lived rally?

Benzinga
Summary
Nutrition label

66% Informative

Cathie Wood's flagship ARK Innovation ETF ( NYSE :ARKK) is up 6% this year , outpacing the S&P 500's 2% gain and the Nasdaq 's 1% increase.

Over the past three years , ARKK 's annualized return is -5.89% and its five-year return barely hits 1.03% .

Last year , ARK Invest bought 170,778 shares of Beam Therapeutics Inc. ( NASDAQ : BEAM ), a move that reinforces her faith in genomics and precision medicine.

VR Score

58

Informative language

57

Neutral language

16

Article tone

formal

Language

English

Language complexity

38

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

14

https://www.benzinga.com/news/25/03/44132684/cathie-woods-bold-move-8-straight-days-of-buying-beam-therapeutics-as-stock-soars-14https://www.benzinga.com/money/qnetic-2?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44132684https://www.benzinga.com/quote/BEAM?getReport=1https://www.investing.com/news/company-news/cathie-woods-ark-buys-beam-therapeutics-sells-adaptive-biotech-stock-93CH-3882383https://www.marketbeat.com/instant-alerts/ark-investment-management-llc-has-17529-million-stake-in-beam-therapeutics-inc-nasdaqbeam-2025-02-26/https://www.benzinga.com/startups/25/02/43466203/warren-buffetts-127-billion-stock-sell-off-sends-wall-street-a-stark-warning-for-2025-below-average-returns-ahead?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44132684https://www.benzinga.comhttps://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9spja3yaad1&utm_source=yahoohttps://www.benzinga.com/money/mode-mobile-2?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44132684https://www.channelchek.com/news-channel/morningstar_analyst_peeks_behind_aark_curtain_and_calls_fund_wretchedhttps://www.investing.com/news/company-news/cathie-woods-ark-buys-beam-therapeutics-sells-adaptive-biotech-stock-93CH-3882383?utm_source=chatgpt.comhttps://www.benzinga.com/money/startengine-own?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44132684https://www.benzinga.com/money/arrived-private-credit-fund?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=44132684https://portfolioslab.com/symbol/ARKK

Affiliate links

no affiliate links